@prefix dcterms: .
@prefix dgn-np: .
@prefix this: .
@prefix rdfs: .
@prefix xsd: .
@prefix sio: .
@prefix ncit: .
@prefix lld: .
@prefix miriam-gene: .
@prefix miriam-pubmed: .
@prefix eco: .
@prefix wi: .
@prefix prov: .
@prefix pav: .
@prefix prv: .
@prefix np: .
@prefix dgn-gda: .
@prefix dgn-void: .
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_head {
this: np:hasAssertion dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_assertion;
np:hasProvenance dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_provenance;
np:hasPublicationInfo dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_publicationInfo;
a np:Nanopublication .
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_assertion a np:Assertion .
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_provenance a np:Provenance .
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_publicationInfo
a np:PublicationInfo .
}
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_assertion {
miriam-gene:7157 a ncit:C16612 .
lld:C0085110 a ncit:C7057 .
dgn-gda:DGNcd1abd85f7e6486b5f9d3c6b875297fc sio:SIO_000628 miriam-gene:7157, lld:C0085110;
a sio:SIO_001121 .
}
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_provenance {
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_assertion dcterms:description
"[In the clinical diagnostic arena: the World Health Organization established a standard nomenclature for intraductal papillary mucinous neoplasms, mucinous cystic tumors, intraductal mucinous hyperplasias, and solid pseudopapillary tumors; focal glandular differentiation may be commonly identified within pancreatic endocrine neoplasms (islet cell tumors) while not necessarily implying an unfavorable prognosis typical of ductal adenocarcinomas; positron emission tomography scanning may be used for evaluation of early tumor response to novel chemotherapeutic regimens; helical computed tomography (CT) is the state of the art in preoperative imaging for pancreatic cancer; neoadjuvant 5-fluorouracil (5-FU)-based chemoradiation in 39 resectable patients provided a median survival of 19 months, actuarial 4-year survival of 19%, and improved local tumor control; gemcitabine has shown promise in alleviating tumor-related symptoms with a significantly better clinical benefit response than single agent 5-FU (23.8 vs. 4.8%, p = 0.0022) based on change in pain intensity, daily analgesic consumption, performance status, and weight; a significant survival advantage was demonstrated in patients treated with conventional therapies whose tumors expressed p21WAF-1, an important inhibitor of cell cycle progression and downstream molecule of p53 and TGF-beta; a p21-adenovirus (rAD-p21) gene therapy resulted in significant growth inhibition of pancreatic cancer cell lines in tissue culture, and development of a successful SCID mouse-human pancreatic adenocarcinoma xenograft model provided an animal model for preclinical trials of rAD-p21.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en;
wi:evidence dgn-void:source_evidence_literature;
sio:SIO_000772 miriam-pubmed:9821173;
prov:wasDerivedFrom dgn-void:befree-2016;
prov:wasGeneratedBy eco:ECO_0000203 .
dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date .
dgn-void:source_evidence_literature a eco:ECO_0000212;
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en;
rdfs:label "DisGeNET evidence - LITERATURE"@en .
}
dgn-np:NP1409086.RAynKNuVtvzenYoiKVrt89ILKQ9bg1QJgQXN_SDB4ey5Y130_publicationInfo {
this: dcterms:created "2016-05-13T12:52:25+02:00"^^xsd:dateTime;
dcterms:rights ;
dcterms:rightsHolder dgn-void:IBIGroup;
dcterms:subject sio:SIO_000983;
prv:usedData dgn-void:disgenetv3.0rdf;
pav:authoredBy , ,
, , ;
pav:createdBy ;
pav:version "v4.0.0.0" .
dgn-void:disgenetv3.0rdf pav:version "v4.0.0" .
}